Policy & Payment

Nine New Value-Based Care Models Move CMS Closer To 2030 Accountable Care Goals

CMS’s new models accelerate a major, multi-year shift in reimbursement toward outcome-based accountability

CMS has accelerated its shift toward value-based care, with nine new payment models announced in late 2025. These new models aim to improve chronic disease care, lower drug costs, and expand accountability for hospital re-admissions, among other goals. Their financial incentives could spur greater use of products such as glucose monitors or wearables to manage chronic disease. CMS’s stated long-range goal is to have all traditional Medicare beneficiaries in accountable care relationships by 2030.

Slow Growth of Accountable Care Participation To Date

Slow Growth of Accountable Care Participation To Date

Source: CMS. Participation Continues To Grow In CMS’ Accountable Care Organization Initiatives In 2024.

One example: the new ACCESS model (Advancing Chronic Care with Effective, Scalable Solutions). ACCESS establishes a new way to pay for ongoing, technology-supported chronic care—such as glucose monitoring or wearables—with a provider incentive linked to positive patient outcomes. Participating organizations enroll Medicare beneficiaries with common chronic conditions and receive a monthly payment to help fund that continuous support. ACCESS uses “outcome-aligned payment” (OAP), where half of the payment is held-back and only released if enough patients hit those targets within a 12-month period.

ACCESS has four clinical pathways, with targets for improving common chronic conditions:

Track Conditions Clinical Measures
Early cardio-kidney-metabolic (eCKM) Hypertension
Dyslidemia
Obesity or overweight
Prediabetes
Blood Pressure
BMI 
A1c  
LDL-C 
Cardio-kidney-metabolic (CKM)  Diabetes 
Chronic kidney disease 
Heart disease 
Blood pressure
Weight/BMI
A1c
LDL-C
CKD
Musculoskeletal  Chronic musculoskeletal pain  Improved physical functioning  
Lower pain intensity  
Behavioral Health  Depression
Anxiety
Improved depression / anxiety screenings

Table 1 Example of how a provider would be paid if caring for 1,000 diabetes patients and achieving the clinical goals over 12 months

ACCESS Model Example

Source: CMS. Advancing Chronic Care With Effective, Scalable Solutions (ACCESS) Model. 2026

Announced Payment Rates For ACCESS Clinical Tracks

Clinical Track Annual Allowed Per Patient Monthly Cash (In-Year) Monthly Withheld (At-Risk) Total Potential Medicare Revenue Per Patient1
Early cardio-kidney-metabolic (e.g., hypertension, prediabetes) $360 $12.00 $12.00 $288
Cardio-kidney- metabolic (e.g. diabetes, kidney disease)  $420 $14.00 $14.00 $336
Chronic musculoskeletal pain  $180 $6.00 $6.00 $144
Behavioral health (depression, anxiety)  $180 $6.00 $6.00 $144

1 Medicare reimburses 80% of the total allowable rate, the remaining 20% comes from patient co-insurance

Source: CMS. Advancing Chronic Care With Effective, Scalable Solutions (ACCESS) Model. 2026

Summary Of New Models Announced At End Of 2025

Model Name Description Participation Model Dates
Long-term Enhanced ACO Design (LEAD) Provides enhanced, flexible cash flow payments to providers to support team-based care and downstream value-based care arrangements. Voluntary January 1, 2027- December 31, 2036
Ambulatory Specialty Model (ASM) Focuses on outpatient specialists treating beneficiaries with heart failure and lower back pain.  Mandatory in specified regions January 1, 2027- December 31, 2031
GENErating cost Reductions fOr U.S. Medicaid (GENEROUS) Lower Medicaid drug spending, aligning with MFN pricing.  Voluntary January 1, 2026-December 31, 2030
Global Benchmark for Efficient Drug Pricing (GLOBE)  Tests new payment calculation based on Part B inflation rebates  Voluntary October 1, 2026-December 31, 2031 
Guarding U.S. Medicare Against Rising Drug Costs (GUARD)  Tests new payment for certain Part D products.  Voluntary January 1, 2027- December 31, 2031 
Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth (BALANCE) Increases access to GLP-1 Medications  Voluntary May 2026-December 2031 
Make America Healthy Again: Enhancing Lifestyle and Evaluating Value-based Approaches Through Evidence (MAHA ELEVATE)  Will award funds for establishing evidence-based, whole-person functional or lifestyle medicine approach to chronic disease care  Voluntary September 1, 2026- August 31, 2029
Wasteful and Inappropriate Service Reduction (WISeR)  Uses AI and machine learning to review claims and reduce fraud, waste, and abuse.  Voluntary January 1, 2026- December 31, 2031 
Advancing Chronic Care with Effective Scalable Solutions (ACCESS) Chronic disease prevention and management using technology. Voluntary July 5, 2026- July 4, 2035

Source: CMS. Advancing Chronic Care With Effective, Scalable Solutions (ACCESS) Model. 2026


May 2026
Anticipate shifts, reduce risk, and decide with confidence — powered by actionable intelligence from the HIDA Knowledge Center.